MedTrace Logo

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

NCT02844465 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2025-01-17

Study results available
· View outcomes & findings →

Summary

The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).

Conditions

  • Temporal Lobe Epilepsy

Interventions

DEVICE

Visualase MRI-Guided Laser Ablation

All subjects will undergo MRI-guided laser ablation of the amygdala and hippocampus with the Visualase System.

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Robert Gross, MD, PhD · Emory University

  • Michael Sperling, MD · Thomas Jefferson University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2023-12-11
Completion
2023-12-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844465 on ClinicalTrials.gov